The past two to three decades have seen a steady increase in the prevalence of
hypertension in China, largely owing to increased life expectancy and lifestyle changes …

Objective To evaluate and quantify the future risk of cardiovascular events in young adults
with high blood pressure. Design Systematic review and meta-analysis. Data sources …

Background The appropriate target for systolic blood pressure to reduce cardiovascular risk
in older patients with hypertension remains unclear. Methods In this multicenter …

Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …

Background: Heart failure (HF) and atrial fibrillation (AF) are growing in prevalence
worldwide. Few studies have assessed to what extent stage 1 hypertension in the 2017 …

High blood pressure (BP) is the leading cause of worldwide cardiovascular disease
morbidity and mortality. Patients and clinicians dealing with hypertension have benefited …

Hypertension is the leading cause of death worldwide, affecting 1.4 billion people.
Treatment options include the widely used calcium channel blockers, among which …

Background Blood pressure (BP) are uncontrolled in over 80% hypertensive population in
China, indicating a compelling need for a pragmatic hypertension management strategy …

For normal‐weight population, the management of prehypertension may be more beneficial
by identifying insulin resistance (IR) status than relying solely on traditional indicators of …

Objective: The 2017 American College of Cardiology/American Heart Association blood
pressure (BP) guidelines lowered the hypertension threshold from a SBP/DBP level of at …